正对的IMiD-Degron对诱导细胞中的选择性蛋白质降解
Patrick J Brennan1,2, Rebecca E Saunders3, Mary Spanou4
1Department of Chemistry, Chemistry Research Laboratory, University of Oxford; Oxford, UK.
bioRxiv : the preprint server for biology
|April 1, 2024
概括
研究人员开发了一种选择性蛋白质降解系统,使用改性免疫调节性胺基药物 (IMiD) 和指 (ZF) 突变物. 这种方法精确地针对蛋白质进行降解,避免细胞组件如IKZF1和IKZF3.3的意外降解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 免疫调节性伊米德药物 (IMiDs) 通过指 (ZF) 降解基因促进向蛋白质降解.
- 现有的IMiD可以降解非预期的细胞蛋白,如IKZF1和IKZF3,限制它们的特异性.
研究的目的:
- 通过设计新的IMiD类似物来设计一种高度选择性的蛋白质降解系统.
- 为了克服与当前基于IMID的蛋白质降解策略相关的缺乏特异性.
主要方法:
- 采用"撞孔"策略来创建突变的ZF蛋白和相应的IMiD类似物.
- 选了8380个ZF突变物与撞击的IMiD类似物进行选,以确定选择性相互作用.
- 验证了该系统降解TRIM28的有效性,TRIM28是一种与疾病相关的蛋白质.
主要成果:
- 开发了一种新的IMiD模拟物,可以选择性降解突变的ZF降解物.
- 证明新系统不会诱导内源蛋白质如IKZF1和IKZF3.3的降解.
- 在概念验证研究中成功应用了TRIM28有针对性的降解系统.
结论:
- 开发的"碰撞和洞"IMID系统为目标蛋白质降解提供了增强的选择性.
- 这项技术为目标验证和潜在的治疗应用中蛋白质敲除提供了有价值的工具.
- 该系统能够降解缺乏已知的小分子结合剂的蛋白质,从而扩大了向蛋白质降解的范围.
相关概念视频
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
The Unfolded Protein Response
4.6K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.6K
Proteins: From Genes to Degradation
12.2K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
12.2K
The Proteasome Structure
749
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
749


